What does Dr. Deroo - Dr. Vanneuville do?

Dr. Deroo - Dr. Vanneuville is a research organisation in Tielt. Private Limited, started on 14 June 2006, 1 establishment.

What is the address of Dr. Deroo - Dr. Vanneuville?

The registered office of Dr. Deroo - Dr. Vanneuville is located at Jan Vinckestraat 4, 8700 Tielt.

Is Dr. Deroo - Dr. Vanneuville still active?

Yes. According to the CBE (1 October 2026) Dr. Deroo - Dr. Vanneuville is active, legal situation “Normale toestand”, started on 14 June 2006.

Is Dr. Deroo - Dr. Vanneuville registered on Peppol?

Yes, Dr. Deroo - Dr. Vanneuville is registered on the Peppol network with ID 0208:0881841153.

What is the enterprise number of Dr. Deroo - Dr. Vanneuville?

The enterprise number of Dr. Deroo - Dr. Vanneuville is BE0881841153.

When was Dr. Deroo - Dr. Vanneuville founded?

Dr. Deroo - Dr. Vanneuville was founded on 14 June 2006.

Who are the directors of Dr. Deroo - Dr. Vanneuville?

According to the 2025 annual accounts, the directors of Dr. Deroo - Dr. Vanneuville are: Benedicte VANNEUVILLE, Kristoff DEROO.

Is Dr. Deroo - Dr. Vanneuville a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 June 2006; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Dr. Deroo - Dr. Vanneuville make in 2025?

Dr. Deroo - Dr. Vanneuville posted a profit after taxes of € 304,687 in financial year 2025.

What is the revenue of Dr. Deroo - Dr. Vanneuville?

As a small company, Dr. Deroo - Dr. Vanneuville is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 511,123.

Dr. Deroo - Dr. Vanneuville (Private Limited) - Tielt

Dossier Dr. Deroo - Dr. Vanneuville, printed on 1 October 2026 from databakkes.be/en/0881841153/dr-deroo-dr-vanneuville. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Deroo - Dr. Vanneuville from Tielt, company number BE0881841153, closed financial year 2025 with a result of € 304,687 after tax. For that financial year Dr. Deroo - Dr. Vanneuville recorded a gross margin of € 511,123 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 300,098 to € 304,687. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 14, 2026.

What it is worth Growing

€ 1.3 million

▲ 22% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 304,687

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 346,572

▲ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 80,879 paid out

27 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 3,899

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 271,794

▼ 30% vs 2024

€ 69,749 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 4,677

▲ € 4,444 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 43,978

▲ 47% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 240,759 Gross margin 2022: € 240,759 First fiscal year in the series	€ 500,133 Gross margin 2023: € 500,133 ▲ 108% vs 2022 (€ 240,759) Favourable step	€ 512,031 Gross margin 2024: € 512,031 ▲ 2% vs 2023 (€ 500,133) Favourable step	€ 511,123 Gross margin 2025: € 511,123 Unchanged (€ 512,031) Unfavourable step
Profit after taxes	€ 113,605 Profit after taxes 2022: € 113,605 First fiscal year in the series	€ 286,657 Profit after taxes 2023: € 286,657 ▲ 152% vs 2022 (€ 113,605) Favourable step	€ 300,098 Profit after taxes 2024: € 300,098 ▲ 5% vs 2023 (€ 286,657) Favourable step	€ 304,687 Profit after taxes 2025: € 304,687 ▲ 2% vs 2024 (€ 300,098) Favourable step	▲ 2%
Equity	€ 541,315 Equity 2022: € 541,315 First fiscal year in the series	€ 777,587 Equity 2023: € 777,587 ▲ 44% vs 2022 (€ 541,315) Favourable step	€ 1,031,758 Equity 2024: € 1,031,758 ▲ 33% vs 2023 (€ 777,587) Favourable step	€ 1,255,566 Equity 2025: € 1,255,566 ▲ 22% vs 2024 (€ 1,031,758) Favourable step	▲ 22%
Total debts	€ 581,938 Total debts 2022: € 581,938 First fiscal year in the series	€ 550,204 Total debts 2023: € 550,204 ▼ 5% vs 2022 (€ 581,938) Favourable step	€ 425,328 Total debts 2024: € 425,328 ▼ 23% vs 2023 (€ 550,204) Favourable step	€ 320,585 Total debts 2025: € 320,585 ▼ 25% vs 2024 (€ 425,328) Favourable step	▼ 25%
Cash	€ 71,900 Cash 2022: € 71,900 First fiscal year in the series	€ 310,176 Cash 2023: € 310,176 ▲ € 238,276 vs 2022 (€ 71,900) Favourable step	€ 221,700 Cash 2024: € 221,700 ▼ 29% vs 2023 (€ 310,176) Unfavourable step	€ 346,572 Cash 2025: € 346,572 ▲ 56% vs 2024 (€ 221,700) Favourable step	▲ 56%
Land & buildings	€ 925,669 Land & buildings 2022: € 925,669 First fiscal year in the series	€ 872,169 Land & buildings 2023: € 872,169 ▼ 6% vs 2022 (€ 925,669) Unchanged	€ 820,451 Land & buildings 2024: € 820,451 ▼ 6% vs 2023 (€ 872,169) Unchanged	€ 767,732 Land & buildings 2025: € 767,732 ▼ 6% vs 2024 (€ 820,451) Unchanged	▼ 6%
Retained profit	€ 535,115 Retained profit 2022: € 535,115 First fiscal year in the series	€ 771,387 Retained profit 2023: € 771,387 ▲ 44% vs 2022 (€ 535,115) Favourable step	€ 1,025,558 Retained profit 2024: € 1,025,558 ▲ 33% vs 2023 (€ 771,387) Favourable step	€ 1,249,366 Retained profit 2025: € 1,249,366 ▲ 22% vs 2024 (€ 1,025,558) Favourable step	▲ 22%
Dividend	€ 36,862 Dividend 2022: € 36,862 First fiscal year in the series	€ 50,385 Dividend 2023: € 50,385 ▲ 37% vs 2022 (€ 36,862) Unchanged	€ 45,927 Dividend 2024: € 45,927 ▼ 9% vs 2023 (€ 50,385) Unchanged	€ 80,879 Dividend 2025: € 80,879 ▲ 76% vs 2024 (€ 45,927) Unchanged	▲ 76%
Bank debt	€ 548,919 Bank debt 2022: € 548,919 First fiscal year in the series	€ 467,885 Bank debt 2023: € 467,885 ▼ 15% vs 2022 (€ 548,919) Favourable step	€ 386,111 Bank debt 2024: € 386,111 ▼ 17% vs 2023 (€ 467,885) Favourable step	€ 271,794 Bank debt 2025: € 271,794 ▼ 30% vs 2024 (€ 386,111) Favourable step	▼ 30%
Balance sheet total	€ 1,123,252 Balance sheet total 2022: € 1,123,252 First fiscal year in the series	€ 1,327,791 Balance sheet total 2023: € 1,327,791 ▲ 18% vs 2022 (€ 1,123,252) Unchanged	€ 1,457,086 Balance sheet total 2024: € 1,457,086 ▲ 10% vs 2023 (€ 1,327,791) Unchanged	€ 1,576,151 Balance sheet total 2025: € 1,576,151 ▲ 8% vs 2024 (€ 1,457,086) Unchanged	▲ 8%

Key figures of Dr. Deroo - Dr. Vanneuville, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Dr. Deroo - Dr. Vanneuville?

What happened at Dr. Deroo - Dr. Vanneuville in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 14, 2026 New annual accounts for financial year 2025: profit of € 304,687 (▲ 2% vs 2024). Source: NBB ↗
Jan 1, 2018 New establishment in Tielt. KBO
2006 Kristoff DEROO became a director. NBB
2006 Benedicte VANNEUVILLE became a director. NBB
Jun 14, 2006 Start of the company according to the CBE. KBO

In short

From € 113,605 profit in 2022 to € 304,687 profit in 2025.

Paid € 477,244 in corporate taxes since 2022.

Best year ever: 2025, with € 304,687 profit.

Paid out € 214,053 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Deroo - Dr. Vanneuville? We notify you, reason included.

Follow Dr. Deroo - Dr. Vanneuville

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Benedicte VANNEUVILLE Kristoff DEROO

Dr. Deroo - Dr. Vanneuville

Behind Dr. Deroo - Dr. Vanneuville are Benedicte VANNEUVILLE and Kristoff DEROO.

See the full network in the app

Directors

According to the 2025 annual accounts

Benedicte VANNEUVILLE

bestuurder

since 2006

Kristoff DEROO

bestuurder

since 2006

Establishments

Establishment units

Physical locations of this company

Registered office

Jan Vinckestraat 4

8700 Tielt

2.303.508.686

Bruggestraat 84

8700 Tielt

Active since 1 January 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0881.841.153

VAT number

BE 0881.841.153

Registered office

Jan Vinckestraat 4, 8700 Tielt

Names & denominations

Dr. Deroo - Dr. Vanneuville

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 June 2006

Peppol

Active · Active since 17 Feb 2025

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Deroo - Dr. Vanneuville

Financials

What happened to Dr. Deroo - Dr. Vanneuville?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions